Breastcancer-genetics
311 – 320 of 2286
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Claudin-4 Expression is Associated with Survival in Ovarian Cancer but Not with Chemotherapy Response
(
- Contribution to journal › Article
-
Mark
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab : Results from the Phase II PROMIX trial
(
- Contribution to journal › Article
-
Mark
Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment
(
- Contribution to journal › Article
-
Mark
High-throughput molecular techniques and personalized treatment for primary breast cancer
2018)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Determinants of variable resource use for multidisciplinary team meetings in cancer care
(
- Contribution to journal › Article
-
Mark
Germline mutations in BRCA1 and BRCA2 incidentally revealed in a biobank research study : experiences from re-contacting mutation carriers and relatives
(
- Contribution to journal › Article
-
Mark
BRCAsearch : written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer
(
- Contribution to journal › Article
-
Mark
Accuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer
(
- Contribution to journal › Article
-
Mark
The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant : Breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
(
- Contribution to journal › Article
-
Mark
The applicability of the translated Edmonton Symptom Assessment System : revised [ESAS-r] in Swedish palliative care
(
- Contribution to journal › Letter